Zhengye Biotechnology Holding (ZYBT) Long-Term Investments (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Long-Term Investments of $30.5 million for Q4 2025, down 22.77% year-over-year from $39.5 million in Q4 2024, and down 22.77% quarter-over-quarter from $39.5 million in Q4 2024.
Zhengye Biotechnology Holding (ZYBT) Long-Term Investments (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Long-Term Investments for 3 consecutive years, with $30.5 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Long-Term Investments fell 22.77% year-over-year to $30.5 million; the TTM figure through Dec 2025 stood at $30.5 million (down 22.77% YoY), while the FY2025 annual figure was $31.0 million, down 20.42% from the prior year.
- Long-Term Investments fell to $30.5 million in Q4 2025 per ZYBT's latest filing, from $39.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $39.5 million in Q4 2024 and bottomed at $30.5 million in Q4 2025.
- Historically, Long-Term Investments has averaged $36.0 million across 3 years, with a median of $37.9 million in 2023.
- Annual changes were most pronounced in 2024 — Long-Term Investments increased 4.32% — and 2025, when it slipped 22.77%.
- Zhengye Biotechnology Holding's Long-Term Investments stood at $37.9 million in 2023, then increased by 4.32% to $39.5 million in 2024, then fell by 22.77% to $30.5 million in 2025.
- Business Quant data shows ZYBT's Long-Term Investments at $30.5 million in Q4 2025, $39.5 million in Q4 2024, and $37.9 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.86 Bn | 42.90 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.54 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.79 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.57 Bn | 22.77 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.71 Bn | 11.18 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 60.00 Mn |
| 10 | Zhengye Biotechnology Holding | 88.07 Mn | 80.75 Mn | - | 30.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.53 Mn |
| Dec 31, 2024 | 39.53 Mn |
| Dec 31, 2023 | 37.89 Mn |